|
SF-36 domains & CLDQ
|
General populations (N = 256,A) mean (SD)
|
CHC without antiviral-treated patients (N = 64,B) Mean (SD)
|
Antiviral-treated CHC patients (N = 64,C) Mean (SD)
|
F¸ (post-hoc multiple comparison) t-test
|
|---|
|
Physical functioning
|
82.79 (22.16)
|
71.95 (29.33)
|
75.86 (21.85)
|
6.57** (A > B)
|
|
Role physical
|
72.95 (41.34)
|
66.07 (45.36)
|
35.94 (44.29)
|
19.19** (A > C&B > C)
|
|
Bodily pain
|
74.26 (17.97)
|
80.63 (25.04)
|
73.30 (22.84)
|
2.88
|
|
General health
|
64.78 (19.96)
|
41.84 (28.57)
|
51.78 (20.99)
|
32.35** (A > C > B)
|
|
Vitality
|
65.33 (16.80)
|
60.94 (25.91)
|
50.00 (25.09)
|
15.01**(A,B > C)
|
|
Social functioning
|
83.35 (15.98)
|
81.53 (22.49)
|
75.23 (24.39)
|
4.78**(A > C)
|
|
Role emotional
|
79.43 (37.72)
|
78.11 (37.70)
|
43.20 (46.66)
|
22.32** (A,B > C)
|
|
Mental health
|
70.91 (14.77)
|
71.88 (18.43)
|
61.00 (20.51)
|
10.10** (A,B > C)
|
|
PCS
|
48.39 (8.52)
|
52.97 (17.20)
|
40.78 (12.50)
|
20.06** (B > A > C)
|
|
MCS
|
49.73 (8.19)
|
49.73 (12.00)
|
46.34 (12.51)
|
3.23* (A > C)
|
|
Abdominal symptom
| |
6.06 (1.30)
|
5.75(1.33)
|
1.31
|
|
Fatigue
| |
5.38(1.56)
|
4.78(1.38)
|
2.31*
|
|
Systemic symptoms
| |
5.71(1.09)
|
4.98(1.06)
|
3.88**
|
|
Activity
| |
5.12(1.51)
|
5.21(1.52)
|
1.01
|
|
Emotional function
| |
5.78(1.16)
|
5.02(1.42)
|
3.30**
|
|
Worry
| |
6.10(1.33)
|
5.95(1.16)
|
0.71
|
- *p < 0.05, **p < 0.01; Age and gender were matched; SD: standard deviation; post-hoc multiple comparison by Scheffe’ method.
